On the surface, importing lower-cost prescription drugs from overseas sounds like an idea anyone would like--after all, it has the potential to save massive amounts of money. But as with other aspects of the healthcare reform debate, things are more complicated than they look. The idea of allowing such imports is opposed strongly by the pharmaceutical industry, and their resistance is creating yet another quagmire in the legislative process. Article